University of British Columbia-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2023

  1. Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

    Journal of Clinical Oncology, Vol. 41, Núm. 18, pp. 3339-3351

2022

  1. Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial

    The Lancet Oncology, Vol. 23, Núm. 3, pp. 362-373

2020

  1. HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studies

    Annals of Oncology, Vol. 31, Núm. 9, pp. 1186-1197